Acute heart failure management in the USA and Japan

overview of practice patterns and review of evidence

Toshikazu D. Tanaka, Mitsuaki Sawano, Ravi Ramani, Mark Friedman, Shun Kosaka

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.

Original languageEnglish
Pages (from-to)931-947
Number of pages17
JournalESC heart failure
Volume5
Issue number5
DOIs
Publication statusPublished - 2018 Oct 1

Fingerprint

Japan
Heart Failure
Medical Manuscripts
Therapeutics
Public Health
Mortality

Keywords

  • Acute heart failure
  • Drug therapy
  • Regional difference

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Acute heart failure management in the USA and Japan : overview of practice patterns and review of evidence. / Tanaka, Toshikazu D.; Sawano, Mitsuaki; Ramani, Ravi; Friedman, Mark; Kosaka, Shun.

In: ESC heart failure, Vol. 5, No. 5, 01.10.2018, p. 931-947.

Research output: Contribution to journalReview article

@article{d657e9498b434d2088e5caf8c70ca2da,
title = "Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence",
abstract = "Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.",
keywords = "Acute heart failure, Drug therapy, Regional difference",
author = "Tanaka, {Toshikazu D.} and Mitsuaki Sawano and Ravi Ramani and Mark Friedman and Shun Kosaka",
year = "2018",
month = "10",
day = "1",
doi = "10.1002/ehf2.12305",
language = "English",
volume = "5",
pages = "931--947",
journal = "ESC heart failure",
issn = "2055-5822",
publisher = "The Heart Failure Association of the European Society of Cardiology",
number = "5",

}

TY - JOUR

T1 - Acute heart failure management in the USA and Japan

T2 - overview of practice patterns and review of evidence

AU - Tanaka, Toshikazu D.

AU - Sawano, Mitsuaki

AU - Ramani, Ravi

AU - Friedman, Mark

AU - Kosaka, Shun

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.

AB - Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.

KW - Acute heart failure

KW - Drug therapy

KW - Regional difference

UR - http://www.scopus.com/inward/record.url?scp=85054100588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054100588&partnerID=8YFLogxK

U2 - 10.1002/ehf2.12305

DO - 10.1002/ehf2.12305

M3 - Review article

VL - 5

SP - 931

EP - 947

JO - ESC heart failure

JF - ESC heart failure

SN - 2055-5822

IS - 5

ER -